Evidence map›Paper›PMID 29920643›Full record

ReviewClinical and experimental immunology2019

The microbiome in autoimmune diseases.

F De Luca, Y Shoenfeld

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 286 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
286citing papers in PubMed, 9 pooled it
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03926286 phase1completednot on this map

Fecal Microbial Transplant for Sjogrens Syndrome

TypeinterventionalSponsorUniversity of MiamiRan2019 to 2020Enrolled10ConditionsSjogren's SyndromeArmsFMP-30
NCT05627089 withdrawnnot on this mapstarted 2023, after this paper: background citation

Rheumatoid Arthritis and Myositis Cohort

TypeobservationalSponsorAttune Health Research, Inc.Ran2023 to 2035Enrolled0ConditionsRheumatoid Arthritis, Myositis
3 · Its place in the literature

Who cites it

286 citing papers in PubMed, 9 syntheses or guidelines pooled it, 503 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. GUTAID: a curated database linking gut microbial antigens to autoimmune mechanisms.Database : the journal of biological databases and curation · 2026
    Article
  20. Article

226 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

F De LucaZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.ORCID 0000-0001-7316-6181
Y ShoenfeldZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Sheba Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microbiome is represented by microorganisms which live in a symbiotic way with the mammalian. Microorganisms have the ability to influence different physiological aspects such as the immune system, metabolism and behaviour. In recent years, several studies have highlighted the role of the microbiome in the pathogenesis of autoimmune diseases. Notably, in systemic lupus erythematosus an alteration of the intestinal flora (lower Firmicutes/Bacteroidetes ratio) has been described. Conversely, changes to the gut commensal and periodontal disease have been proposed as important factors in the pathogenesis of rheumatoid arthritis. At the same time, other autoimmune diseases (i.e. systemic sclerosis, Sjögren's syndrome and anti-phospholipid syndrome) also share modifications of the microbiome in the intestinal tract and oral flora. Herein, we describe the role of the microbiome in the maintenance homeostasis of the immune system and then the alterations of the microorganisms that occur in systemic autoimmune diseases. Finally, we will consider the use of probiotics and faecal transplantation as novel therapeutic targets.

Indexed as

AnimalsAutoimmune DiseasesDysbiosisFecal Microbiota TransplantationGastrointestinal MicrobiomeHomeostasisHumansImmunity, InnateMicrobiotaProbioticsanti-phospholipidautoimmune diseasesfaecal transplantationmicrobiomeprobioticsrheumatoid arthritisSjögren’s syndromesyndrome systemic lupus erythematosussystemic sclerosis

Identifiers

PMID29920643
PMCPMC6300652
OpenAlexW2809017655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.